Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2012 Results
Date:11/8/2012

ny believes that, similar to the presentation of adjusted net income and adjusted net income per diluted share, these non-GAAP financial measures are also helpful in understanding the company's 2012 financial guidance, particularly in light of the effect of various acquisition and divestiture transactions effected by the company during 2012. They are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with the consolidated financial statements prepared in accordance with GAAP. 

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995This press release contains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals' future financial results and growth potential, including 2012 financial guidance, future product development and other statements that are not historical facts.  These forward-looking statements are based on Jazz Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with maintaining and increasing sales of and revenue from Xyrem, such as the potential introduction of generic competition and changed or increased regulatory restrictions on Xyrem, as well as similar risks related to effectively commercializing the company's other marketed products, including Erwinaze and Prialt; successfully integrating and growing Jazz Pharmaceuticals' combined business operations after the Azur Pharma merger and EUSA Pharma acquisition, which may be more difficult, time-consuming or costly than expected, particularly in light of the company's expanded international footprint; obtaining appropriate pricing and reimbursement for the compan
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
2. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
3. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
4. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
5. Genoa Pharmaceuticals announces $1.2M Financing
6. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
7. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
8. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
9. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
10. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
11. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Glades Drugs, an independent pharmacy ... proud to announce its expansion into a new corporate headquarters ... feature an 8,000-square-foot office space and state of the art ... for 100 open positions for the new facility. ... Road will serve as the chain,s corporate headquarters and closed ...
(Date:8/20/2014)... 2014 Reportlinker.com announces ... in its catalogue: EMR 2014: The ... http://www.reportlinker.com/p0833392/EMR-2014-The-Market-for-Electronic-Medical-Records.html Kalorama has continuously ... (EMR) for nearly a decade, and each year ... Our report has become the industry standard, oft-quoted ...
(Date:8/19/2014)... , Aug. 19, 2014  The Alabama Supreme Court, ... patients can sue drug makers who mislead doctors into believing ... side‑effects.  The case is Weeks v. Wyeth, and the decision ... in that same case last year. Heninger Garrison Davis attorneys ... the patient in the case, Danny Weeks . ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2EMR 2014: The Market for Electronic Medical Records 2EMR 2014: The Market for Electronic Medical Records 3EMR 2014: The Market for Electronic Medical Records 4EMR 2014: The Market for Electronic Medical Records 5EMR 2014: The Market for Electronic Medical Records 6EMR 2014: The Market for Electronic Medical Records 7EMR 2014: The Market for Electronic Medical Records 8Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
... Corporation (NASDAQ: THOR ), a world leader ... and restore failing hearts, today announced that it will ... Wednesday, February 8. The company will hold ... operating activities, open to all interested parties, at 1:30 ...
... PuraMed BioScience, Inc. (OTCBB: PMBS) announced today that ... natural product for the treatment of migraine headaches, is ... Drug Chain in the United States. With the addition ... in approximately 15,000 stores nationwide. "We are ...
Cached Medicine Technology:Thoratec Schedules Fourth Quarter Conference Call, Webcast 2PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States 2
(Date:8/20/2014)... 20, 2014 The National Association ... $1.24 million Science Education Partnership Award (SEPA) grant ... NAHN’s collaborative project with the Hispanic Communications Network ... , This collaborative NIH R25 program has been ... linguistic diversity among health professionals by recruiting and ...
(Date:8/20/2014)... City, New Jersey (PRWEB) August 20, 2014 ... in meeting the needs of an estimated tens of ... introduction of the new Bill A3525—a bill that would ... patients to grow their own cannabis—earlier this summer by ... horticultural training for medicinal quality marijuana is growing. , ...
(Date:8/20/2014)... 20, 2014 Verndale is pleased to ... list; an exclusive list ranking the fastest-growing private companies ... according to their yearly percentage revenue growth over a ... on the Inc. 5000 list where it ranked number ... offers its clients a wide range of digital marketing ...
(Date:8/20/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief operating officer ... Ore. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... healthcare organization serving a population of more than 35,000 ...
(Date:8/20/2014)... Biosimilars, which are similar versions ... an abbreviated process, could reap billions in health ... Services, Inc.’s (AIS) Specialty Pharmacy News offers coverage ... Food and Drug Administration’s (FDA) recent acceptance of ... , Drugmaker Sandoz said July 24 that the ...
Breaking Medicine News(10 mins):Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 3Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3
... a scheme that would provide safe drinking water to the ... day after the Bollywood star Aamir Khan offered his support ... Gaur told IANS that a Rs.17-crore (Rs.10.7 million) scheme has ... in the 13 gas-hit localities of Bhopal was contaminated. ...
... is a breather for those who suffer from severe ... revealed that breathing a special gas mixture may help ... Patients revealed that after breathing the gas, their endurance ... breath. These findings have been published in the American ...
... revolution of sorts. A clue into what might be ... at reducing// or totally obliterating the side-effects by evolving ... information. Indeed this will be a whole new story ... M. Issa, a pharmacologist and clinical epidemiologist is the ...
... what extent their perception influences our behavior has often intrigued ... Current Directions in Psychological Science reveals that that we are ... in which their feelings are expressed towards us. This is ... thought process. ,Infact, these perceptions often linger in the ...
... antiviral coating on bank notes, vending machines and photocopiers ... ,Materials researcher Guagang Ren at Queen Mary ... metal, metal oxide and ceramic nanoparticles that have strong ... ,Applying the coatings to buttons on ...
... issue of Current Directions in Psychological Science finds that other ... The article explains that we are tied to each other. ... feelings can be a contagious, strong influence. ,Explaining ... the influences of other people that affect us without our ...
Cached Medicine News:Health News:State Govt To Provide Safe Drinking Water To Bhopal Gas Victims 2Health News:COPD Patients portray improved exercise performance after breathing a Special Gas 2
... AMO Prestige System marked an amazing ... of safety with high-performance fluidics.A.S.E.T. keeps ... conditions in the in the anterior ... the reaction and interaction of the ...
Highly versatile, efficient, compact and accurate digital readout display....
... system has all the features of phaco ... engineering means minimal maintenance. Small, light and ... to site. Lowest cost reusable tubing kit ... longer is there a price objection to ...
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Medicine Products: